|
Date
|
Event
|
|---|---|
|
March 3rd, 2026 |
Review and approval of the draft Separate Statements and the Consolidated Statements for the financial year ended 31 December 2025 Analyst conference call |
|
May 5th, 2026 |
Annual general meeting for the adoption of the Financial Statements for the financial year ended 31 December 2025 |
|
May 6th, 2026 |
Review and approval of the additional periodic financial information* for the period ended 31 March 2026 Analyst conference call |
|
July 29th, 2026 |
Review and approval of the 2026 half-year report Analyst conference call |
|
November 4th, 2026 |
Review and approval of the additional periodic financial information* for the period ended 30 September 2026 Analyst conference call |
* Additional periodic financial information consists in: Revenue by division, Adjusted EBITDA, Adjusted EBIT, EBITDA, EBIT, Operating cash flow, Profit before tax.
The potential payment of the dividend related to the 2025 results will happen in the month of May 2026.